Comparison 11. Intravaginal misoprostol plus injectable uterotonics versus injectable uterotonics.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Postpartum haemoglobin	1	200	Mean Difference (IV, Fixed, 95% CI)	1.0 [0.72, 1.28]
1.1 800 mcg	1	200	Mean Difference (IV, Fixed, 95% CI)	1.0 [0.72, 1.28]
2 Use of Additional Uterotonics	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.32, 28.35]
2.1 800 mcg	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	3.0 [0.32, 28.35]
3 Any shivering	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	2.5 [0.50, 12.59]
3.1 800 mcg	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	2.5 [0.50, 12.59]
4 Nausea	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	2.5 [0.50, 12.59]
4.1 800 mcg	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	2.5 [0.50, 12.59]
5 Vomiting	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.21, 4.84]
5.1 800 mcg	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.21, 4.84]
6 Pyrexia (>= 38 C)	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	2.0 [0.62, 6.43]
6.1 800 mcg	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	2.0 [0.62, 6.43]